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Summary.-We have studied 30 patients presenting with breast cancer and 36 control
patients admitted to hospital for minor surgery. Stool specimens were obtained for
bile acid analysis and bacterial nuclear dehydrogenation activity (NDC) estimation.
The mean total faecal bile acid (FBA) concentration (,tmol/g) in patients with breast
cancer was 15-6 + 1-8 s.e., significantly lower than for control patients (20.5 + 1-9).
NDC were isolated from the faeces of58% ofbreast cancer patients and 15% of control
patients,this differencebeing statisticallyhighlysignificant(P<0.005). Increased bile-
acid degradation by bacteria in the large bowel may explain the reduced FBA con-
centration in patients with breast cancer. Increased NDC isolation in breast-cancer
patients suggests that oestrogen production in the colon may play a role in the
aetiology of breast cancer in some patients.
IT HAS BEEN RECOGNIZED for some time
that endocrine factors may be involved in
the initiation and promotion of human
breast cancer. Ovariectomy, adrenalec-
tomy andhypophysectomy have been used
to curtail the growth of some breast
tumours, while more recently oestrogen-
receptor analysis has been used to identify
tumours most likely to respond to hor-
monal manipulation (Beatson, 1896; Jen-
sen et al., 1971; McGuire et al., 1975).
Oestrogen-dependent tumours have been
described (Caldwell et al., 1971) and it is
now well documented that oestrogens can
stimulate the development of breast
tumours once they have been induced
(King, 1971). There is also evidence to
suggest that oestrogens may induce
tumour cell proliferation (McMahon &
Cole, 1969) but this remains open to
question.
The incidence of breast cancer is high in
North America and in North-West Europe
and low in Africa, Asia and South America
(Doll et al., 1970). Epidemiological studies
encompassing genetic factors, cultural
factors, environmental factors and econo-
mic factors suggest that diet, in particular
an increased intake of fat, correlates best
with the incidence of breast cancer (Wyn-
der, 1968). In these respects the epidemi-
ology of breast cancer closely resembles
that of colorectal cancer (Drasar & Irving,
1973). It is recognized that diet has a
significant influence on the intestinal
substrate, digestive enzymes and large-
bowel flora. Hill has postulated that
biochemically active bacteria in the large-
bowel flora may degrade the colonic
substrate thereby producing carcinogens
or co-carcinogens (Hill et al., 1971a). This
hypothesis, originally formulated as a
possible aetiology for colorectal cancer,
has been modified by Hill to explain the
epidemiological findings in breast cancer
(Hill et al., 1971b). Populations living on
high-fat diets tend to have a faecal flora
containing a higher proportion of meta-
bolically active anaerobic bacteria capable
of degrading the steroid nucleus (Hill &
Aries, 1971). These populations also ex-
crete greater amounts of faecal bile acids
(FBA) which may serve as a substrate for
the metabolically active bacteria (Aries
etal., 1969). It has been demonstrated that
oestradiol, oestrone and 17-methoxy-oes-FAECAL BILE ACIDS, CLOSTRIDIA AND BREAST CANCER
tradiol can be produced in vitro from
colonic substrate by intestinal bacteria, in
particular Clostridium paraputrificum, an
anaerobe which may exhibit nuclear
dehydrogenation activity (Hill et al.,
1971b). It has therefore been postulated
that a significant production of oestrogens
in the large bowel may promote or even
initiate the growth of breast cancer in
humans. The aim of our study was to
measure in Glasgow, the principal city
in an area with a very high incidence of
breast cancer, FBA concentration and the
incidence of a metabolically active bac-
terium in the faeces ofpatients with breast
cancer.
PATIENTS AND METHODS
Patients.-We have studied 30 patients
with histologically confirmed breast cancer
admitted to the Western Infirmary, Glasgow.
All patients were admitted for investigation
and management ofa breast lump, and faecal
samples were obtained from the first stool
passed by each patient following admission to
hospital. Thirty-six patients of both sexes
with no evidence of malignancy or gastro-
intestinal disease were also studied as con-
trols. These patients were admitted to
hospital for minor surgery and faecal samples
were obtained before general anaesthesia.
About 0 5 g of faeces was placed in a bijoux
bottle containing 4-5 ml of sterile transport
medium which was then stored at -20°C to
await bacteriological analysis. The remainder
of the faecal sample was stored in a plastic
container at -20°C to await biochemical
analysis.
Twenty-eight patients in the study group
were diagnosed as having breast cancer by
the frozen-section technique carried out on a
biopsy sample of the breast lump obtained
under general anaesthesia. Twenty-seven
patients then underwent simple mastectomy
with sampling of the ipsilateral axillary
nodes, whilst one 33-year-old woman under-
went a reconstructive mastectomy at a later
date. Two patients did not undergo mast-
ectomy. Ovariectomy was performed in one
of these, to treat widespread metastases
diagnosed at the time of initial presentation,
whilst the second was treated with deep
X-ray therapy for a fungating breast lump
which was not considered to be operable at
the time of admission. In both these patients
the diagnosis of breast cancer was confirmed
histologically from needle biopsy samples of
the breast lump performed under local anal-
gesia.
Biochemical methods.-The method used
for extracting bile acids from the faeces was
based on the technique first described by
Evrard & Janssen (1968) and modified by
Hill & Aries (1971). The faecal samples were
weighed, homogenized with a known amount
of water, and freeze-dried. Steroids were
extracted with glacial acetic acid and
toluene. After this the neutral steroids were
removed with petroleum ether, and the bile
acids extracted with chloroform. Sodium
borohydride conversion was then carried out
before re-extraction of the bile acids with
ethyl acetate. Total FBA content was then
estimated using the hydroxysteroid dehydra-
genase assay described by Iwata & Yamo-
saki (1964) and expressed as ,umol/g freeze-
dried faeces.
Bacteriological methods. Clostridium para-
putrificum (CPP) was isolated by plating out
6 10-fold dilutions of the thawed faecal sus-
pension on to Willis and Hobbs Egg Yolk
Agar. These plates were incubated in an-
aerobic jars at 37°C for 48 h. After incubation
a plate containing 100 non-opalescent
colonies was selected, and a minimum of 10 of
these colonies were subcultured in Robert-
son's Cooked Meat Broth. After a further 48h
anaerobic incubation at 37°C the sub-
cultured colonies were Gram-stained to
identify spore-forming Clostridia, and sub-
cultured on to brain-heart infusion agar
plates for a further 24h aerobic incubation at
37°C, to identify aerobic contaminants. Pure
cultures of CPP were stored at 4°C to await
testing for dehydrogenation activity. The
ability of CPP to metabolize steroids was
tested by incubating a culture in Todd
Hewitt Broth containing the substrate 5/
androstan,3,17-dione. The presence of the
unsaturated product zX4 androstene,3,17-
dione, estimated by thin-layer chromato-
graphy in chloroform and acetone, indicated
a culture of biochemically active CPP com-
monly referred to as nuclear dehydrogenating
Clostridia (NDC).
RESULTS
The 30 breast-cancer patients reported
in this study are considered to be rep-
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resentative of patients presenting for
treatment in the West of Scotland with
this disease. The mean age of the patients
was 62 years with a range of 33 to 93. The
mean age ofthe 36 control patients was 65.
Twenty breast-cancer patients were mar-
ried, 4 widowed and 6 single. Twenty-three
patients (770%) were postmenopausal by at
least 3 years, 1 was menopausal and 6
(20%) premenopausal. Nineteen of the
30 breast-cancer patients had children,
but only 9 of these 19 had breast-fed their
children for more than 2 weeks. Nineteen
patients had cancer of the left breast,
8 had cancer of the right breast and 3 had
cancer in both breasts at presentation.
Histologically, 15 breast tumouirs w-ere
scirrhous (45%), 7 spheroidal (21%), 4
anaplastic and 4 intraduct carcinoma.
All patients were investigated during
their in-patient postoperative convales-
cence, in an attempt to define the stage of
their breast cancer. Staging was based on
clinical examination, axillary-node status,
liver-function tests, ultrasonic examina-
tion of the liver, isotope liver scan and
isotol)e bone scan. Table I gives details of
TABLE I.-Staging andfollouw-up ofpatients
wSith breast carcinoma
Number
Follow-up (months)
No recuirence
Local recurrence
Distant metastases
I)ead
Stage at suigery
I II ITI
15 11 2'
22 28 17
10 (67o/,) 5 (450o) 0
4 4 i2
5 1
1 : I
IN,
12
0
the initial staging of the 30 breast-cancer
patients and also summarizes the main
findings on follow-up. After a mean follow-
up of 25 months, 67% and 45%o of those
patients initially diagnosed as Stage I or II
respectively were alive and well with no
evidence of recurrent tumour. One out of
15 and 3/11 patients diagnosed initially
as Stage I or II respectively had died,
whilst 3/4 with Stage III or IV were dead.
Total FBA results are shown in Table II.
The breast-cancer patients were found to
TABLE II. Mean faecal bile acid concen-
trations and frequency of isolation of
Clostridium paraputificum (CPP) and
NDC
Breast
caIIcer
Alean FBA + s.e.
( umol/g faeces)
0 With CPI'
0 W\ithl NIX
Controls
ii= :36
15 6± + I 205-+ 1.9
62 31
58 15
P
<0 05
< 005
<0005
excrete less bile acid in their faeces (1 56
Hmol/g) than the control patients (20.5
pmol/g), the difference between the groups
reaching statistical significance (P < 0.05).
The mean FBA concentrations for female
control patients (n = 16) and male control
patients (n= 20) have been compared, and
no statistically significant difference noted.
Of the breast-cancer patients, postmeno-
pausal women had a mean FBA concentra-
tion of 18a3 Hmol/g, which was significantly
lower than the corresponding value for the
6 pre-menopausal women (19.85 [Lmol/g).
CPP was isolated from the faeces of 620/0
of patients with breast cancer and 31 0/ of
control patients (Table II). The meta-
bolically active bacterium (NDC) was
isolated from the faeces of 58% of breast
cancer patients as opposed to 1500 of
control patients. This difference is highly
significant (P < 0.005). No statistically
significant difference was found between
the percentage of male and female control
patients from whom NDC was isolated.
Breast-cancer patients with NDC in their
faeces had a mean FBA concentration of
12-8 Hmol/g, compared to 16-8 ,umol/g for
those without NDC in their faeces. This
difference just failed to reach statistical
significance owing to the variability in the
FBA concentrations of patients without
NDC in their faeces.
DISCUSSION
Epidemiological studies of cancers of
the breast and colon have shown them to
be highly correlated with each other, and
with a lhigh fat and animal protein diet
(Drasar & Irving, 1973). The demonstra-
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tion of significant in vitro oestrogen pro-
duction from colonic substrate containing
cholesterol and bile acids by metabolically
active anaerobic gut bacteria such as
NDC may in part explain the correlation
between the two cancers. Significant oes-
trogen production in the large bowel may
promote or even initiate the development
of breast cancer, whilst other degradation
products as yet unidentified may act as
carcinogens orco-carcinogens tothe colonic
mucosa.
Studies of endogenous oestrogen levels
in the urine or plasma of healthy women
at risk of developing breast cancer due to
family history or previous benign breast
disease have failed to show a consistent
relationship between oestrogen levels and
the degree of risk (Hawkins, 1980). Dif-
ferences have been described, however, in
the patterns of oestrogen excretion be-
tween races with a high risk of breast
cancer and those with a low risk (McMahon
et al., 1 973). Recent studies in postmeno-
pausal women with established breast
cancer have found significant increases in
both urinary oestrogen excretion and the
biologically active fraction of oestradiol-
17f in the plasma (Morreal et al., 1979;
Siiteri, 1979). The normal endogenous pro-
ductioni of oestradiol in the female is
about 0 5 mg/day (Hellman et al., 1970).
A pure culture of NDC has been shown to
produce an 80o yield of 17-methoxy-
oestradiol in vitro. Sinice healthv subjects
living on a normal Western diet excrete on
average 600 mg ofacid andneutral steroids
in their faeces per day it is clear that the
contribution of the gut bacteria to oestro-
gen production could be highly significant
(Hill et al., 1971b).
The nature ofthe study necessitated the
exclusion from both, study and control
groups of patients with symptoms of
gastrointestinal disease and patients who
had received an antibiotic within I month
of admission to hospital. All patients in
the study had lived in the W;'est of Scot-
land during the 5 years before admission,
and all stated that they were eating a
normal diet with no medically advised or
self-imposed restrictions. Males were in-
cluded in the control group for this study
of women with breast cancer, since analy-
sis of the control group based on sex
showed no statistically significant differ-
ence in mean age, FBA concentration or
NDC isolation from the faeces. The
observed differences between the control
group and the study group remain statis-
tically significant when data from the male
control patients is excluded.
This study has shown that women with
established breast cancer excrete sig-
nificantly less FBA and have significantly
more NDC in their faeces than control
patients. Similar results have been ob-
tained from a preoperative study of 37
patients with recently diagnosed colorectal
cancer (Murray et al., 1980). Reduced
FBA excretion in patients with breast
cancer and colorectal cancer may result
from an increase in breakdown ofa neutral
or acid steroid-rich colonic substrate by
some bacteria in the colon capable of
metabolizing steroids. One such bacterium
(NDC) has been shown to occur more
frequently in the faeces of patients with
breast cancer and colorectal cancer than in
control subjects. Our findings in this study
of patients with breast cancer make it less
likely that the similar findings in our pre-
vious study of patients with colorectal
cancer were simply due to the presence of
an established tumour in the large bowel.
The search for carcinogenic or co-
carcinogenic degradation products in the
faeces of patients with colorectal cancer
continues. The results ofthis study suggest
that the significance of in vivo production
of oestrogens in the colon merits evalua-
tion. Further work in this field may lead
to an explanation for the epidemiological
correlation between breast cancer and
colorectal cancer.
This stucly as stipported by a grant firom the,
Cancer Research Carnpaign.
REFERENCES
ARIES, V. C., CnROwTHER, J. S., DRASAR, B. S., HILL,
1\..J. & WmILLIAMs, R. E. 0. (1969) Bacteria aIn(d
aetiology of cancer of the large bo-wel. Gut, 10 334.
60860 W. R. MURRAY, A. BLACKWOOD, K. C. CALMAN AND C. MACKAY
BEATSON, G. T. (1896) On the treatment of inoper-
able cases of carcinoma of the mammae; Sugges-
tions for a new method of treatment with illustra-
tive cases. Lancet, ii, 104.
CALDWELL, B. V., TILLSON, S. A., ESBER, H. &
THORNEYCROFT, I. H. (1971) Survival of tumours
after immunization against oestrogens. Nature,
231, 118.
DOLL, R., MUIR, P. & WATERHOUSE, J. (Eds) (1970)
Cancer Incidence in Five Continents. Vol. 2.
Berlin: Springer-Verlag.
DRASAR, B. S. & IRVING, D. (1973) Environmental
factors and cancer of the colon and breast. Br. J.
Cancer, 27, 167.
EVRARD, E. & JANSSEN, S. (1968) Gas-liquid
chromatographic determination of human faecal
bile acid. J. Lipid Res., 9, 226.
HAWKINS, R. A. (1980) Oestrogens and breast
cancer: Present position. Scott. Med. J., 25, 152.
HELLMAN, L., BRADLOW, H. L. & ZUMOFF, B. (1970)
Recent advances in human steroid metabolism.
Adv. Clin. Chem., 13, 1.
HILL, M. J. & ARIES, V. C. (1971) The effect of some
factors on faecal concentration of acid steroids,
neutral steroids and urobilins. J. Pathol., 104, 239.
HILL, M. J., DRASAR, B. S., ARIES, V. C., CROWTHER,
J. S., HAWKESWORTH, G. & WILLIAMS, R. E. 0.
(1971a) Bacteria and aetiology of cancer of the
large bowel. Lancet, i, 95.
HILL, M. J., GODDARD, P. & WILLIAMS, R. E. 0.
(1971b) Gut bacteria and aetiology of cancer of
the breast. Lancet, ii, 472.
IWATA, T. & YAMASAKI, K. (1964) Enzymatic deter-
mination and thin layer chromatography of bile
acids in blood. J. Biochem., 56, 424.
JENSEN, E. V., BLOCK, G. E., SMITH, S., KYSER, K.
& DE SOMBRE, E. R. (1971) Estrogen receptors and
breast cancer response to adrenalectomy. J. Natl
Cancer Inst., 34, 55.
KING, R. J. B. (1971) Are oestrogens carcinogens?
InSome Implications ofSteroid Hormonesin Cancer.
Ed. Williams & Briggs. London: Heinemann
p. 62.
McGuIRE, W. L., CARBONE, P. P., SEARS, M. E. &
ESCHER, G. C. (1975) Estrogen receptors in human
breast cancer: An overview. In Estrogen Receptors
in Human Breast Cancer. Ed. McGuire et al. New
York: Raven Press. p. 1.
MCMAHON, B. & COLE, P. (1969) Endocrinology and
epidemiology of breast cancer. Cancer, 24, 1146.
MCMAHON, B., COLE, P. & BROWN, J. (1973) Etiology
of human breast cancer: A review. J. Natl Cancer
Inst., 50, 21.
MORREAL, C. E., DAO, T. L., NEMOTO, T. &
LONERGAN, P. A. (1979) Urinary excretion of
estrone, estradiol and extriol in post-menopausal
women with primary breast cancer. J. Natl Cancer
Inst., 63, 1171.
MURRAY, W. R., BLACKWOOD, A., TROTTER, J. M.,
CALMAN, K. C. & MACKAY, C. (1980) Faecal bile
acids and clostridia in the aetiology of colorectal
cancer. Br. J. Cancer, 41, 923.
SIITERI, P. K. (1979) Hormonal basis of risk factors
for endometrial and breast cancer. Symp. 6, 1st
Int. Congr. Hormones Cancer, Rome.
WYNDER, E. L. (1968) Current concepts of the aeti-
ology of breast cancer. In Prognostic Factors in
Breast Cancer. Eds. Forrest & Kunkler. London:
Longman. p. 32.